Does OLANZAPINE Cause Dyslipidaemia? 230 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 230 reports of Dyslipidaemia have been filed in association with OLANZAPINE (Olanzapine). This represents 0.5% of all adverse event reports for OLANZAPINE.
230
Reports of Dyslipidaemia with OLANZAPINE
0.5%
of all OLANZAPINE reports
0
Deaths
113
Hospitalizations
How Dangerous Is Dyslipidaemia From OLANZAPINE?
Of the 230 reports, 113 (49.1%) required hospitalization, and 2 (0.9%) were considered life-threatening.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLANZAPINE. However, 230 reports have been filed with the FAERS database.
What Other Side Effects Does OLANZAPINE Cause?
Drug ineffective (5,139)
Weight increased (3,588)
Off label use (3,256)
Toxicity to various agents (3,175)
Somnolence (2,612)
Sedation (2,130)
Suicide attempt (2,116)
Confusional state (1,898)
Condition aggravated (1,810)
Overdose (1,765)
What Other Drugs Cause Dyslipidaemia?
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
PREDNISONE (148)
Which OLANZAPINE Alternatives Have Lower Dyslipidaemia Risk?
OLANZAPINE vs OLANZAPINE\SAMIDORPHAN L-MALATE
OLANZAPINE vs OLAPARIB
OLANZAPINE vs OLARATUMAB
OLANZAPINE vs OLECLUMAB
OLANZAPINE vs OLIVE OIL\SOYBEAN OIL